BofA lowered the firm’s price target on Crocs (CROX) to $98 from $99 and keeps a Buy rating on the shares. Q2 was “disappointing,” but the firm sees a path toward revenue growth bottoming out in Q3 and improving into 2026, says the analyst, who expects management to hit Q3 guidance and expects Crocs brand revenues to sequentially improve in Q4 driven by better international results. The firm is modestly lowering its FY25 EPS estimate by 1% to $11.30 to reflect forex and lower Heydude revenues in Q4, the analyst noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CROX:
- Optimistic Outlook for Crocs: Buy Rating Affirmed Amid Anticipated Revenue Rebound and Strategic Leadership
- Crocs Faces Challenges in Sales and Margins Amidst Rising Competition and Product Strategy Concerns
- Crocs downgraded to Negative from Mixed view at BWG Global
- Crocs Stock (CROX) Jumps on New Sydney Sweeney Ad Campaign
- Pfizer to acquire Metsera, Oracle names new CEOs: Morning Buzz